Literature DB >> 22988032

Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection.

Max W Richardson1, Julie Jadlowsky, Chuka A Didigu, Robert W Doms, James L Riley.   

Abstract

CCR5, a cell surface molecule critical for the transmission and spread of HIV-1, is dynamically regulated during T cell activation and differentiation. The molecular mechanism linking T cell activation to modulation of CCR5 expression remains undefined. Kruppel-like factor 2 (KLF2) is a transcription factor that promotes quiescence, survival, and in part by modulating chemokine receptor levels, induces homing to secondary lymphoid organs. Given the relationship between T cell activation and chemokine receptor expression, we tested whether the abundance of KLF2 after T cell activation regulates CCR5 expression and, thus, susceptibility of a T cell to CCR5-dependent HIV-1 strains (R5). We observed a strong correlation between T cell activation, expression of KLF2 and CCR5, and susceptibility to infection. To directly measure how KLF2 affects CCR5 regulation, we introduced small interfering RNA targeting KLF2 expression and demonstrated that reduced KLF2 expression also resulted in less CCR5. Chromatin immunoprecipitation assays identified KLF2 bound to the CCR5 promoter in resting but not CD3/28 activated T cells, suggesting that KLF2 directly regulates CCR5 expression. Introduction of KLF2 under control of a heterologous promoter could restore CCR5 expression and R5 susceptibility to CD3/28 costimulated T cells and some transformed cell lines. Thus, KLF2 is a host factor that modulates CCR5 expression in CD4 T cells and influences susceptibility to R5 infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988032      PMCID: PMC3466370          DOI: 10.4049/jimmunol.1201431

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

Review 1.  Chemokines and T lymphocytes: more than an attraction.

Authors:  S G Ward; K Bacon; J Westwick
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

2.  Gene organization and promoter function for CC chemokine receptor 5 (CCR5).

Authors:  F Guignard; C Combadiere; H L Tiffany; P M Murphy
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

3.  Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

4.  Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.

Authors:  B L Levine; W B Bernstein; M Connors; N Craighead; T Lindsten; C B Thompson; C H June
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

5.  LKLF: A transcriptional regulator of single-positive T cell quiescence and survival.

Authors:  C T Kuo; M L Veselits; J M Leiden
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

6.  Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.

Authors:  J L Riley; B L Levine; N Craighead; T Francomano; D Kim; R G Carroll; C H June
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons.

Authors:  S Mummidi; S S Ahuja; B L McDaniel; S K Ahuja
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

Review 8.  The role of co-stimulation in regulation of chemokine receptor expression and HIV-1 infection in primary T lymphocytes.

Authors:  R G Carroll; J L Riley; B L Levine; P J Blair; D C St Louis; C H June
Journal:  Semin Immunol       Date:  1998-06       Impact factor: 11.130

9.  Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.

Authors:  M Mack; B Luckow; P J Nelson; J Cihak; G Simmons; P R Clapham; N Signoret; M Marsh; M Stangassinger; F Borlat; T N Wells; D Schlöndorff; A E Proudfoot
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

10.  Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule.

Authors:  J L Riley; K Schlienger; P J Blair; B Carreno; N Craighead; D Kim; R G Carroll; C H June
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  15 in total

1.  HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.

Authors:  Andrew T Hale; Chris T Longenecker; Ying Jiang; Sara M Debanne; Danielle E Labatto; Norma Storer; Anne Hamik; Grace A McComsey
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

2.  Establishment of mouse leukemia cell lines expressing human CD4/CCR5 using lentiviral vectors.

Authors:  Ya-Jing Li; Fu-Yan ZhuGe; Chang-Chun Zeng; Jin-Yang He; Ning Tan; Juan Liang
Journal:  Virus Genes       Date:  2016-12-28       Impact factor: 2.332

Review 3.  Is the CCR5 Δ 32 mutation associated with immune system-related diseases?

Authors:  Khodayar Ghorban; Maryam Dadmanesh; Gholamhossein Hassanshahi; Mohammad Momeni; Mohammad Zare-Bidaki; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 4.  CAR T cells for infection, autoimmunity and allotransplantation.

Authors:  Colby R Maldini; Gavin I Ellis; James L Riley
Journal:  Nat Rev Immunol       Date:  2018-10       Impact factor: 53.106

5.  HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms.

Authors:  Delphine Planas; Yuwei Zhang; Patricia Monteiro; Jean-Philippe Goulet; Annie Gosselin; Nathalie Grandvaux; Thomas J Hope; Ariberto Fassati; Jean-Pierre Routy; Petronela Ancuta
Journal:  JCI Insight       Date:  2017-08-03

6.  The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.

Authors:  S T Ward; K K Li; E Hepburn; C J Weston; S M Curbishley; G M Reynolds; R K Hejmadi; R Bicknell; B Eksteen; T Ismail; A Rot; D H Adams
Journal:  Br J Cancer       Date:  2014-11-18       Impact factor: 7.640

7.  Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells.

Authors:  Benjamin Trinité; Chi N Chan; Caroline S Lee; Saurabh Mahajan; Yang Luo; Mark A Muesing; Joy M Folkvord; Michael Pham; Elizabeth Connick; David N Levy
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

8.  Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.

Authors:  Aurélie Cleret-Buhot; Yuwei Zhang; Delphine Planas; Jean-Philippe Goulet; Patricia Monteiro; Annie Gosselin; Vanessa Sue Wacleche; Cécile L Tremblay; Mohammad-Ali Jenabian; Jean-Pierre Routy; Mohamed El-Far; Nicolas Chomont; Elias K Haddad; Rafick-Pierre Sekaly; Petronela Ancuta
Journal:  Retrovirology       Date:  2015-12-10       Impact factor: 4.602

9.  Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.

Authors:  Anupama Ganesh; Donna Lemongello; Evelyn Lee; Julia Peterson; Bridget E McLaughlin; April L Ferre; Geraldine M Gillespie; Dietmar Fuchs; Steven G Deeks; Peter W Hunt; Richard W Price; Serena S Spudich; Barbara L Shacklett
Journal:  AIDS Res Hum Retroviruses       Date:  2016-05-02       Impact factor: 2.205

10.  Genetic and Epigenetic Regulation of CCR5 Transcription.

Authors:  Rutger J Wierda; Peter J van den Elsen
Journal:  Biology (Basel)       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.